Delivery Order SPE2DB22D3016-SPE2DB24FACW8
Award Date
11/10/23
Potential Completion Date
11/13/23
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,737.03, is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a medical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 15, 2023. The contract does not have a set-aside designation, indicating open competition....
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product BREVIBLOC 2,000 MG/100 ML BAG 100ML. The contract has a ceiling value of $3,356.52 and a period of performance through April 18, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,963.48 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide BREVIBLOC 2,000 MG/100 ML BAG 100ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.24 firm fixed-price contract is for the supply of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a medical product. This award is under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,276.42 for the supply of BREVIBLOC 2,500 MG/250 ML BAG 250ML. The contract, awarded by the Defense Logistics Agency (DLA), has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
This federal contract award, valued at $2,289.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a medical product, with a period of performance ending on September 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999...
This federal contract award was issued by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp for the delivery of BREVIBLOC 2,000 MG/100 ML BAG 100ML. The contract, valued at $3,068.20, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. The contract has a firm fixed price pricing type and an ultimate completion date of August 16, 2024....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of BREVIBLOC 2,000 MG/100 ML BAG 100ML, a pharmaceutical product. The delivery order is valued at $9,995.45 and has a firm fixed price. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,873.19 firm fixed price delivery order is for the supply of BREVIBLOC, a 2,000 mg/100 ml bag of medication. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, with a potential value of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bridion 200 mg/2 ml vials, a pharmaceutical product. The contract has a ceiling value of $1,768.67 and a completion date of February 20, 2024. This appears to be a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...